Navigation Links
New Biotech Drugs to Aid in Renal Cell Carcinoma Treatment

Two biotech drugs produced by Bayer AG, Pfizer and Onyx pharmaceuticals are astounding doctors with their effects on decreasing the progression// of metastatic kidney cancer.

The drugs, sunitinib (marketed under brand name Sutent) and sorafenib (brand name Nexavar) have been found to delay the progression of renal cell carcinoma by 3 to 6 months.

Renal cell carcinoma is the most common of all kidney cancers; 90 percent of kidney cancers diagnosed in the US are due to this cancer. It is responsible for 1.5 percent of all cancer deaths and around 30,000 cases of renal cell carcinoma are diagnosed every year.

The standard drugs used are interferon alfa and interleukin-2. Yet these drugs help in only 5 percent of cases where the tumors have spread. Hence the excitement over the new drugs.

Researchers from US, France and Poland, contributed to the results of the study published in the New England Journal of Medicine.

The studies report how sunitinib when given to patients slowed the progression of the disease or development of tumors, to 11 months as against 5 months with interferon alfa. This was tested on 375 cancer patients.

In the case of sorafenib, half of 903 volunteers from 19 countries were put on the drug, while the other half received a placebo. Those who took the drug showed an extra period of around 3 months in delay of tumor growth.

The results were so effective that doctors are now thinking of placing the control patients on the drug.

Yet side effects of the drugs persist and can be severe in some patients. They include skin rashes, diarrhea and increased blood pressure.

Both drugs work by inhibiting the blood flowing to the tumor and hence limiting its growth.

"Kidney cancer has always been regarded as a cancer in which there was no progress," explains the lead author of the sunitinib study, Dr. Robert Motzer from Memorial Sloan-Kettering Cancer Center in Ne
'"/>




Page: 1 2

Related medicine news :

1. Biotechnology industry expected to grow into a three billion dollar industry by 2002
2. Biotechnology on the lead
3. Panacea Biotech To Market Anthrax Vaccine
4. Commercialization of Biotech Discoveries, An Encouragement For Researchers
5. Biotech drug causing anemia-EPREX
6. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
7. Biologicals Transfer Proposal between US and Indian Biotechnology
8. Vical Biotech and NIH jointly develops HIV vaccine
9. Biotechnology Initiatives Planned In Hyderabad
10. Biotech Osiris to go public
11. Western Region Tops in Indian Biotech Growth
Post Your Comments:
(Date:10/10/2008)...a) levels boost cardiovascular disease risk for s...ews) -- If you,re worried about reducing your risk...you should quit smoking, eat a healthful diet, exe..., and make sure your cholesterol levels aren,t too... (a) levels are? , Well, if you don,t have a f...
(Date:10/10/2008).... 10 /PRNewswire/ -- Do you think that the blind,c...own? Attend the October,17 open house at the Virgi... Impaired, and see how instructors there empower t... fulfilling lives through non-visual,techniques ta...zalea Avenue, is holding an open house to,celebrat...
(Date:10/10/2008)... Topics range from bullying to incorporating PD...Vocus) October 10, 2008 -- Several pediatric exper...be presenting at the 2008 American Academy of Pedi...uns from October 11 - 14 in Boston. Presenters and...Best, MD, MPH, will present "Promoting Smoke-...
(Date:10/10/2008).... 10 /PRNewswire-USNewswire/ -- Public interest,ad...g convened to make,decisions on the threats posed ...0 October 2008, the 2nd UNEP(2) Open Ended Working...hat would form part of a global framework,on mercu...(GC) in February,2009, where it will be decided wh...
Breaking Medicine News(10 mins):Health News:Little-Known Fat Can Be a Heartbreaker 2Health News:Little-Known Fat Can Be a Heartbreaker 3Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:Children's National Experts Presenting at American Academy of Pediatrics Conference 2Health News:Elements for a UN Global Framework on Mercury Agreed to 2
...on of colon cancer is made possible by Colonoscopy...ing procedure that helps to nip treatable cancers ...and other researchers from the Medical School at Y...significant rise in colonoscopy screening that hel...
... the amalgamation of medicine and modern communica... The ability to monitor patients at a distance mea... unnecessary visits to the doctor, which also save...r scientist at the Fraunhofer Institute for Integr...
... Laura Bush had a skin cancer tumour removed from ...he wife of US President George W. Bush had a biops...rtly before US congressional elections, White Hous... said Monday evening. Doctors identified it as a ...
...er Anbumani Ramadoss Monday stressed the need for ...standard and counterfeit drugs.// "States should c..., generate information and prepare dossiers on the...tion with all the stakeholders to facilitate curbi...
Other Medicine News:Health News:Colonoscopy Aids Early Detection of Colon Cancer 2Health News:Telemedicine Offers New Possibilities in Health Care 2
(Date:10/7/2008)...NT, Mich., Oct. 7 /- McLaren Health C...ring some of the world,s leading medical,minds to ... breast and,gastrointestinal cancer treatments. Th...CI, was organized by McLaren,s Sukamal Saha, M.D.,...n sentinel node mapping for,colorectal cancer has ...
(Date:10/7/2008)...TIN, Texas, Oct. 7 /- The Texas Cardi...cal Center has been selected as one of,only a few ...ved clinical,trial for a new device to treat persi...treatment, training and research center specializi...ween St. David,s Medical Center and,Texas Cardiova...
(Date:10/7/2008)...COUVER, Oct. 7 / Burcon Nut...that its Puratein(R) and,Supertein(TM) canola prot...e) for their intended use in a variety of food and...f-affirmed GRAS through an,independent evaluation ...ood safety, toxicology, nutritional sciences, food...
(Date:10/7/2008)...NNA, Va., Oct. 7 /- CEL-SCI... has entered into a Material Transfer,Agreement (M...l Center,(NIHCC) and the laboratory of Dr. Frances...r basis of changes to the tumor microenvironment,c...ncola is the Chief of,the Infectious Disease and I...
Breaking Medicine Technology:News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 3CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3Taming Your Temper 3A Learning to Turn Down the Heat 25611 1Taming Your Temper 3A Learning to Turn Down the Heat 25611 2New insights into the regulation of PTEN tumor suppression function 4545 1New insights into the regulation of PTEN tumor suppression function 4545 2InstaCare Corp Continues Turnaround 26 Reports 291 25 Revenues Increase in 2Q 2008 7249 1InstaCare Corp Continues Turnaround 26 Reports 291 25 Revenues Increase in 2Q 2008 7249 2InstaCare Corp Continues Turnaround 26 Reports 291 25 Revenues Increase in 2Q 2008 7249 3InstaCare Corp Continues Turnaround 26 Reports 291 25 Revenues Increase in 2Q 2008 7249 4InstaCare Corp Continues Turnaround 26 Reports 291 25 Revenues Increase in 2Q 2008 7249 5InstaCare Corp Continues Turnaround 26 Reports 291 25 Revenues Increase in 2Q 2008 7249 6NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 4540 1NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 4540 2NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 4540 3NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 4540 4NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 4540 5
...BUSINESS WIRE)--Mar 27, 2007 - Interleukin,Genetic...sity of,California San Diego today reported at the...t associations between coronary artery,disease (CA...),levels appear to be dependent on pro-inflammator...a presentation titled "The Influence of Oxidized,P...
...ns Reached in Key Lung Compartments, REINACH and B...tCall/ -- Arpida Ltd. today announced promising,re... radiolabelled,Human Microdose studies included a ...breaking study is the first ever using Microdosing...ung compartments.,The results showed that AR-709 a...
Other Medicine Technology:ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 2ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 3Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 2Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 3Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 4Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 5
Unshielded
...s an advanced multi-modality system. The Easy II P...32-channel digital EEG amplifier with seven active... like airflow, respiratory effort and snoring. The...s, a built-in pulse oximeter, and a body position ...
...b Salvage System offers five different products fo... these components are cobalt-chrome, ultra high mo...RDIAN products are extensions of Wright Medical Te...s. , ,The distal femur consists of a rotating hin...
...m features 270 accessibility and the most compact,... diameter available (54 inches). Multichannel imag...r coils, increased patient comfort, and shorter ex...a. , ,The Magnetom C! comes equipped with work...
Medicine Products: